2-Hour Virtual Seminar on Confidentiality of Substance Use Disorder Patient Records; Complying with 42 CFR Part 2 - ResearchAndMarkets.com

DUBLIN, January 26, 2022--(BUSINESS WIRE)--The "2-Hour Virtual Seminar on Confidentiality of Substance Use Disorder Patient Records; Complying with 42 CFR Part 2" webinar has been added to ResearchAndMarkets.com's offering.

This webinar will cover the law on confidentiality of substance use disorder patient records under 42 CFR part 2. This law was previously known as the confidentiality of drug abuse and alcohol abuse records.

The new law originally was effective in 2017 and a second law was effective February 2, 2018. Updates occurred in 2020 and hospitals are still struggling to determine what they need to do to meet compliance.

Anyone or any facility that is subject to these requirements needs to attend this webinar. All hospitals should have a policy and this program will address what needs to be in the policy. This is true even for hospitals that do not have dedicated units to treat patients with drug and alcohol problems, now known as substance abuse disorders. Changes and updates implemented in 2020 will also be discussed.

The webinar will discuss what is required of part 2 programs. A facility that receives federal assistance (such as Medicare) and hold itself out as providing substance use disorder diagnosis, treatment, or referral must follow these extensive regulations. They address the notice that must be given to the patient. It discusses patient access to medical records and what must be in the consent form.

It discusses research, closure of a program, new definitions, minors, decease patient records, security of medical records, disclosure, when disclosure is prohibited and more.

Areas Covered in the Session:

• Introduction and history

• Substance use disorder patient records

• How to locate a copy of the law

• Substance use disorder data

• Purpose and need of new law

• Who is subjected to the law under part 2

• 2018 changes: disclosures with patient consent, audit and evaluation, abbreviated notice on redisclosure, etc.

• 2020 changes regarding disclosures

• Sub-regulatory guidance

• Notice to patients of confidentiality requirements

• Patient access to medical records and restrictions on use

• Reports of violations or penalties

• General provisions

• Definitions

• Minor patient

• Deceased patient

• Security of medical records

• Restrictions on disclosure

• Crimes on the premises and child abuse reports

• Prohibitions on re-disclosure

• Relationship to state laws

• Disclosures with consent

• Disclosures to the criminal justice system

• Disclosure without consent

• Medical emergencies

• Court orders

• Informants and undercover agents

• Closing a program

• Research

• Audits and evaluation

• FAQs

• OCR and HIPAA and mental health records

Who Should Attend:

• Staff that care for of patients in a federally assisted program and who holds themselves out as providing care and treatment to patients with a substance use disorder (SUD)

• Program directors

• Risk managers

• Health information management director and staff

• Nurses

• Physicians

• Mid-level providers

• Compliance officers

• Hospital legal counsel

• Clinicians who use a controlled substance for detoxification or maintenance treatment of withdrawal of a SUD

For more information about this webinar visit https://www.researchandmarkets.com/r/sfr2fo.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220126005777/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900